HSBC Holdings’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

HSBC Holdings’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,901	Closed	-$17.9K	–	3153
2022 Q4	$17.9K	Sell	11,901 -434	-4%	-$704	﹤0.01%	3018
2022 Q3	$21K	Sell	12,335 -551	-4%	-$779	﹤0.01%	2871
2022 Q2	$17K	Sell	12,886 -152	-1%	-$260	﹤0.01%	3200
2022 Q1	$31K	Hold	13,038	–	–	﹤0.01%	3223
2021 Q4	$61K	Hold	13,038	–	–	﹤0.01%	3191
2021 Q3	$105K	Hold	13,038	–	–	﹤0.01%	2885
2021 Q2	$130K	Buy	13,038 +8	+0.1%	+$65	﹤0.01%	2821
2021 Q1	$113K	Sell	13,030 -244	-2%	-$2.68K	﹤0.01%	2626
2020 Q4	$140K	Buy	+13,274	New	+$145K	﹤0.01%	2900

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HSBC Holdings's GRTX Position: Q1 2023 in Review

HSBC Holdings sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2023, closing a stake of 11,901 shares — an estimated $17.9K sold.

HSBC Holdings first reported a position in GRTX in Q4 2020 and held it in 9 quarters. The position peaked at $140K in Q4 2020. 40 funds tracked by Wall St. Rank hold GRTX as of Q1 2023.

HSBC Holdings reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
HSBC Holdings sold 11,901 Galera Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $17.9K.
HSBC Holdings first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
HSBC Holdings's Galera Therapeutics, Inc. Common Stock position peaked at $140K in Q4 2020.
40 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.